Pioneering pharmacy professionals celebrated in 2022 ‘Women to Watch’ list
For this year’s list, 12 women were selected for breaking boundaries and improving patient care.…
News
See all-
A third of patients have high blood pressure under community pharmacy case-finding service
-
Sotrovimab no longer recommended as first-line treatment for COVID-19 patients
-
NHS to spend up to £28.6m on campaign directing patients to community pharmacy for minor ailments
-
NHS England expands eligibility for life-extending prostate cancer treatment
-
‘Strong certainty’ that e-cigarettes are better than other nicotine replacement therapy for quitting smoking, review finds
Sign in now if you’re an RPS member or subscriber.
Become a member of the RPS or subscribe to gain unlimited access.
News from Wales
Wales is first UK nation to publish guidance on analgesic stewardship
Hospital pharmacists in England and Wales to be balloted on industrial action
Direct referral to pharmacies among goals of updated plan for Welsh pharmacy
Additional 130 community pharmacies sign up to offer independent prescribing service
First cohort to begin Welsh post-registration foundation pharmacist programme
RPS launches latest workforce wellbeing survey
Industrial action could lead hospital pharmacists to withdraw from weekend rotas, warns union leader
News from Scotland
NHS staff offered 7.5% average pay rise in Scotland
Scottish epilepsy medicines registry to deliver data by end of 2022
Hospital pharmacists encouraged to reject ‘insulting’ government pay offer
Pharmacy closures debate is ‘undermining public confidence’, says RPS Scotland director
Scottish health minister backs protected learning time for pharmacists
RPS launches latest workforce wellbeing survey
Cannabis-based Sativex approved for NHS use in Scotland
Genomics
Adverse drug reactions reduced by nearly one third after genetic testing, major trial results to show
How we set up the UK’s first clopidogrel genomics testing system
Everything you need to know about the NHS genomic medicine service
DPYD genetic testing and the future of pharmacogenomic testing in routine care
First pharmacogenomic testing service to be launched by pharmacy multiple later in 2022
We cannot ignore race when it comes to pharmacogenomics
Cancer pharmacogenomics testing: are we hitting the mark?
Learning & CPD
Monoclonal antibodies for the treatment of multiple myeloma
Mental health considerations in older women
Diagnosis and management of type 2 diabetes mellitus
Atrial fibrillation: symptoms, diagnosis and management
Case-based learning: management of complex regional pain syndrome with a transdermal unlicensed medication
How to conduct a clinical audit in six steps
Supporting patients on new direct oral anticoagulant medicines
Gastrointestinal system diseases
See all-
Inflammatory bowel disease: symptoms and diagnosis
-
Inflammatory bowel disease: treatment and management
-
FDA approves two new drugs for irritable bowel syndrome
-
Antihistamine reduces pain in irritable bowel syndrome
-
Optimising therapy for inflammatory bowel disease
-
Management of patients with inflammatory bowel disease: current and future treatments
-
Management of acute upper gastrointestinal bleeding
-
Understanding irritable bowel syndrome: bugs, brains and leaky barriers
Want to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
Errors and the inappropriate use of medicines in UK care homes
-
Clinical impact of CFTR modulator therapy roll-out
-
Should menopause management differ between ethnic groups?
-
The role of circulating tumour DNA in guiding cancer treatment and future applications
-
3D printing of pharmaceuticals and the role of pharmacy
-
Addressing drug–microbiome interactions: the role of healthcare professionals